Review
Management of newly diagnosed metastatic carcinoma of the prostate
- PMID: 6428022
Item in Clipboard
Review
Management of newly diagnosed metastatic carcinoma of the prostate
Urol Clin North Am.
1984 May.
Abstract
Metastatic prostatic cancer can be present in a variety of different ways. The authors describe the differences among stages D-0, D-1, and D-2 disease and present the treatment options for each of the substages. They summarize and integrate the clinical evidence that bears on the potential efficacy of each treatment.
Similar articles
-
Current management of prostatic carcinoma.Prim Care. 1985 Dec;12(4):795-813. Prim Care. 1985. PMID: 3909178 Review.
-
Management of metastatic prostatic cancer.Urology. 1985 Feb;25(2 Suppl):49-52. Urology. 1985. PMID: 3918376
-
[What is safe in the therapy of advanced prostatic cancer?].Internist (Berl). 1985 Dec;26(12):765-70. Internist (Berl). 1985. PMID: 3936819 German. No abstract available.
-
Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.Urology. 1986 Jan;27(1 Suppl):21-8. Urology. 1986. PMID: 3079935 Clinical Trial.
-
[Prostatic carcinoma in a young adult: a case report].Hinyokika Kiyo. 1990 May;36(5):617-22. Hinyokika Kiyo. 1990. PMID: 1698013 Review. Japanese.
Cited by
-
Advances in the treatment of metastatic prostatic cancer.West J Med. 1985 Sep;143(3):342-5. West J Med. 1985. PMID: 2413632 Free PMC article.
-
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.Br J Cancer. 1995 May;71(5):1061-4. doi: 10.1038/bjc.1995.204. Br J Cancer. 1995. PMID: 7734300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical